These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 22410492)

  • 1. Monocyte subpopulations and cardiovascular risk in chronic kidney disease.
    Heine GH; Ortiz A; Massy ZA; Lindholm B; Wiecek A; Martínez-Castelao A; Covic A; Goldsmith D; Süleymanlar G; London GM; Parati G; Sicari R; Zoccali C; Fliser D;
    Nat Rev Nephrol; 2012 Mar; 8(6):362-9. PubMed ID: 22410492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease.
    Rogacev KS; Seiler S; Zawada AM; Reichart B; Herath E; Roth D; Ulrich C; Fliser D; Heine GH
    Eur Heart J; 2011 Jan; 32(1):84-92. PubMed ID: 20943670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography.
    Rogacev KS; Cremers B; Zawada AM; Seiler S; Binder N; Ege P; Große-Dunker G; Heisel I; Hornof F; Jeken J; Rebling NM; Ulrich C; Scheller B; Böhm M; Fliser D; Heine GH
    J Am Coll Cardiol; 2012 Oct; 60(16):1512-20. PubMed ID: 22999728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocyte heterogeneity in human cardiovascular disease.
    Zawada AM; Rogacev KS; Schirmer SH; Sester M; Böhm M; Fliser D; Heine GH
    Immunobiology; 2012 Dec; 217(12):1273-84. PubMed ID: 22898391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower Apo A-I and lower HDL-C levels are associated with higher intermediate CD14++CD16+ monocyte counts that predict cardiovascular events in chronic kidney disease.
    Rogacev KS; Zawada AM; Emrich I; Seiler S; Böhm M; Fliser D; Woollard KJ; Heine GH
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2120-7. PubMed ID: 25060791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human monocyte heterogeneity--a nephrological perspective.
    Rogacev KS; Heine GH
    Nephrol Ther; 2010 Jul; 6(4):219-25. PubMed ID: 20447885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shift of monocyte subsets along their continuum predicts cardiovascular outcomes.
    Cappellari R; D'Anna M; Bonora BM; Rigato M; Cignarella A; Avogaro A; Fadini GP
    Atherosclerosis; 2017 Nov; 266():95-102. PubMed ID: 29017104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two different strategies for human monocyte subsets gating within the large-scale prospective CARE FOR HOMe Study.
    Zawada AM; Fell LH; Untersteller K; Seiler S; Rogacev KS; Fliser D; Ziegler-Heitbrock L; Heine GH
    Cytometry A; 2015 Aug; 87(8):750-8. PubMed ID: 26062127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD14(++)CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients.
    Heine GH; Ulrich C; Seibert E; Seiler S; Marell J; Reichart B; Krause M; Schlitt A; Köhler H; Girndt M
    Kidney Int; 2008 Mar; 73(5):622-9. PubMed ID: 18160960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Innate Immune System and Cardiovascular Disease in ESKD: Monocytes and Natural Killer Cells.
    Dounousi E; Duni A; Naka KK; Vartholomatos G; Zoccali C
    Curr Vasc Pharmacol; 2021; 19(1):63-76. PubMed ID: 32600233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Kidney Disease Induces Inflammatory CD40+ Monocyte Differentiation via Homocysteine Elevation and DNA Hypomethylation.
    Yang J; Fang P; Yu D; Zhang L; Zhang D; Jiang X; Yang WY; Bottiglieri T; Kunapuli SP; Yu J; Choi ET; Ji Y; Yang X; Wang H
    Circ Res; 2016 Nov; 119(11):1226-1241. PubMed ID: 27992360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern of human monocyte subpopulations in health and disease.
    Ożańska A; Szymczak D; Rybka J
    Scand J Immunol; 2020 Jul; 92(1):e12883. PubMed ID: 32243617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subgroups of monocytes predict cardiovascular events in patients with coronary heart disease. The PHAMOS trial (Prospective Halle Monocytes Study).
    Höpfner F; Jacob M; Ulrich C; Russ M; Simm A; Silber RE; Girndt M; Noutsias M; Werdan K; Schlitt A
    Hellenic J Cardiol; 2019; 60(5):311-321. PubMed ID: 31055050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis.
    Zimmermann HW; Seidler S; Nattermann J; Gassler N; Hellerbrand C; Zernecke A; Tischendorf JJ; Luedde T; Weiskirchen R; Trautwein C; Tacke F
    PLoS One; 2010 Jun; 5(6):e11049. PubMed ID: 20548789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset.
    Zawada AM; Rogacev KS; Rotter B; Winter P; Marell RR; Fliser D; Heine GH
    Blood; 2011 Sep; 118(12):e50-61. PubMed ID: 21803849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standardized flow cytometry assay for identification of human monocytic heterogeneity and LRP1 expression in monocyte subpopulations: decreased expression of this receptor in nonclassical monocytes.
    Ferrer DG; Jaldín-Fincati JR; Amigone JL; Capra RH; Collino CJ; Albertini RA; Chiabrando GA
    Cytometry A; 2014 Jul; 85(7):601-10. PubMed ID: 24639232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The "Intermediate" CD14
    Wildgruber M; Aschenbrenner T; Wendorff H; Czubba M; Glinzer A; Haller B; Schiemann M; Zimmermann A; Berger H; Eckstein HH; Meier R; Wohlgemuth WA; Libby P; Zernecke A
    Sci Rep; 2016 Dec; 6():39483. PubMed ID: 27991581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of TRIM21-mRNA expression during monocyte maturation.
    Lenart M; Rutkowska-Zapała M; Szatanek R; Węglarczyk K; Stec M; Bukowska-Strakova K; Gruca A; Czyż J; Siedlar M
    Immunobiology; 2017 Mar; 222(3):494-498. PubMed ID: 27773663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppression and monocyte subsets.
    Rogacev KS; Zawada AM; Hundsdorfer J; Achenbach M; Held G; Fliser D; Heine GH
    Nephrol Dial Transplant; 2015 Jan; 30(1):143-53. PubMed ID: 25313167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation profiling reveals differences in the 3 human monocyte subsets and identifies uremia to induce DNA methylation changes during differentiation.
    Zawada AM; Schneider JS; Michel AI; Rogacev KS; Hummel B; Krezdorn N; Müller S; Rotter B; Winter P; Obeid R; Geisel J; Fliser D; Heine GH
    Epigenetics; 2016 Apr; 11(4):259-72. PubMed ID: 27018948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.